Dimensional Fund Advisors’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-351
Closed -$36K 3440
2023
Q3
$36K Sell
351
-185
-35% -$35.9K ﹤0.01% 3405
2023
Q2
$167K Buy
+536
New +$135K ﹤0.01% 3266
2022
Q4
Sell
-441
Closed -$155K 3506
2022
Q3
$155K Sell
441
-118
-21% -$54.7K ﹤0.01% 3278
2022
Q2
$245K Sell
559
-303
-35% -$168K ﹤0.01% 3221
2022
Q1
$653K Sell
862
-375
-30% -$308K ﹤0.01% 3088
2021
Q4
$1.54M Sell
1,237
-174
-12% -$281K ﹤0.01% 2919
2021
Q3
$2.85M Sell
1,411
-556
-28% -$1.19M ﹤0.01% 2743
2021
Q2
$4.9M Buy
1,967
+840
+75% +$2.06M ﹤0.01% 2618
2021
Q1
$2.8M Buy
+1,127
New +$3.35M ﹤0.01% 2759

Other funds holding MBIO

Dimensional Fund Advisors's MBIO Position: Q4 2023 in Review

Dimensional Fund Advisors sold out of Mustang Bio (MBIO) in Q4 2023, closing a stake of 351 shares — an estimated $36K sold.

Dimensional Fund Advisors first reported a position in MBIO in Q1 2021 and held it in 9 quarters. The position peaked at $4.9M in Q2 2021. 25 funds tracked by Wall St. Rank hold MBIO as of Q4 2023.

  • Dimensional Fund Advisors reported no remaining Mustang Bio position as of Q4 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 351 Mustang Bio shares in Q4 2023, an estimated $36K.
  • Dimensional Fund Advisors first reported a position in Mustang Bio in Q1 2021 and held it in 9 quarters.
  • Dimensional Fund Advisors's Mustang Bio position peaked at $4.9M in Q2 2021.
  • 25 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2023.

Based on Dimensional Fund Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.